Presentation TCT 2013 TCT-19. The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus Presenter: Elvin Kedhi October 29, 2013
Presentation TCT 2013 TCT-5. Relationship Between High Platelet Reactivity on Clopidogrel and Outcomes After DES Implantation: Two-Year Results From the ADAPT-DES Study Presenter: Thomas Stuckey October 29, 2013
Presentation TCT 2013 Update on the Global Registry of Degenerative Bioprosthetic Valves Presenter: Danny Dvir October 29, 2013
Presentation TCT 2013 Use Of 4 French Systems For Treating Fem-Pop Lesions: Advantages And Disadvantages: Lessons From The 4EVER Trial Using Astron Pulsar Stents And No Closure Devices Presenter: Koen Keirse October 29, 2013
Presentation Efficient Evaluation for TAVR: What Do We Really Need? Presenter: John Webb October 29, 2013
Presentation TCT 2013 Profile of Patients with Atrial Fibrillation in 2013: From the Highly Symptomatic Athlete to the Asymptomatic 85-Year-Old Presenter: Mintu Turakhia October 29, 2013
Presentation TCT 2013 TCT-67. The First Establishment of Early Healing Profile, 9-month Neointimal Growth, and 24 Months Outcomes of the Dual Therapy Endothelial Progenitor Cell Capturing... Presenter: Stephen Lee October 29, 2013
Presentation TCT 2013 Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety Presenter: Lian R. Gao October 29, 2013
Presentation TCT 2013 Three Dimensional Reconstructions of the Left Phrenic Nerve Anatomy in Relation to the Coronary Venous System Presenter: Julianne Spencer October 29, 2013
Presentation TCT 2013 When and How Should We Treat Functional MR? Perspective from a Heart Failure Specialist Presenter: Ulrich Jorde October 29, 2013